InsidersTradesSigma
Explore the full record of transactions filed by Wu Yifang, Dirigeant. Insider active across 1 companies, notably Everest Medicines Ltd.. Cumulatively, 5 disclosures have been recorded. The latest transaction was filed on 13 May 2026 — Purchase. Regulator: HKEX. All data is accessible without signup.
5 of 5 declarations
Wu Yifang is an executive at Everest Medicines Ltd. He is involved in managing the operations and strategy of the company in the pharmaceutical sector. Wu Yifang collaborates with the management team to develop innovative solutions and meet market needs. His role is essential in ensuring the growth and competitiveness of Everest Medicines.